PAVmed
PAVM
105 hedge funds and large institutions have $65.4M invested in PAVmed in 2021 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 30 increasing their positions, 28 reducing their positions, and 30 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 28
0.01% more ownership
Funds ownership: 0.06% → 0.07% (+0.01%)
3% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 30
2% less funds holding
Funds holding: 107 → 105 (-2)
11% less call options, than puts
Call options by funds: $740K | Put options by funds: $833K
67% less capital invested
Capital invested by funds: $199M → $65.4M (-$133M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$8.48M |
| 2 |
Two Sigma Advisers
New York
|
+$7.23M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$6.51M |
| 4 |
Renaissance Technologies
New York
|
+$4.48M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$3.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.1M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$6.57M |
| 3 |
State Street
Boston,
Massachusetts
|
-$6.18M |
| 4 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$3.2M |
| 5 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$2.42M |
PAVM Hedge Fund Activity: Q4 2021 in Review
105 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q4 2021, worth a combined $65.4M — down 67% from $199M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of PAVM and 29 opened new positions — a net loss of 1 holder — while 28 trimmed existing stakes and 30 added.
The largest buyer was Two Sigma Investments, opening a new position worth an estimated $8.48M. The largest seller was Fidelity Investments, exiting entirely with an estimated $12.1M sold.
- 105 institutional investors held PAVmed (PAVM) as of Q4 2021, down from 107 in Q3 2021.
- Funds reported $65.4M of PAVmed stock for Q4 2021, down 67% quarter-over-quarter.
- 29 funds opened new PAVmed positions in Q4 2021 and 30 closed out, a net change of -1 holder.
- The largest PAVmed buyer in Q4 2021 was Two Sigma Investments, an estimated $8.48M added.
- The largest PAVmed seller in Q4 2021 was Fidelity Investments, an estimated $12.1M sold.
Based on aggregated 13F filings for Q4 2021.